Clinical Trial

The Experience of Giving Birth With Remifentanil for Pain Relief: A Qualitative Study of Mothers and Midwives

Completed
View on ClinicalTrials.gov →
Summary
Background: Remifentanil is an ultra-short-acting opioid used for labor pain relief in several countries, offering stronger analgesia than nitrous oxide but less than epidural anesthesia. While internationally established, remifentanil has not yet been implemented in Denmark. Objective: This study aims to explore and deepen our understanding of the childbirth experience with remifentanil for pain relief, from both the birthing woman's and the midwife's perspectives. Methods: A qualitative study based on interviews with women who gave birth using remifentanil and the midwives involved in their care.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-06-12; most recent amendment 2026-04-01.
Status change: Recruiting → Completed 2026-04-01
Trial Details
NCT Number NCT07030777
Lead Sponsor Nordsjaellands Hospital
Conditions Pain Management in Pregnant Women, Remifentanil, Midwife, Qualitative Research, Birth, Labour Analgesia
Enrollment 40 participants
Start Date 2025-03-01
Primary Completion 2025-06-30 (estimated)
Study Completion 2025-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-07